• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎中溶血磷脂酰胆碱酰基转移酶 3 减少导致的肝实质细胞凋亡:非依赖性机制。

Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis.

机构信息

Division of Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Japan.

出版信息

J Gastroenterol Hepatol. 2019 Jul;34(7):1256-1262. doi: 10.1111/jgh.14461. Epub 2018 Sep 23.

DOI:10.1111/jgh.14461
PMID:30160786
Abstract

BACKGROUND AND AIMS

Lipotoxicity causes liver inflammation, which leads to non-alcoholic steatohepatitis (NASH). Lysophosphatidylcholine (LPC) is a causal agent of lipotoxicity. Recently, lysophosphatidylcholine acyltransferase (LPCAT) was identified as an enzyme that catalyzes the esterification of LPC, which potentially decreases LPC levels. However, the effect of LPCAT in lipotoxicity of the liver is not fully understood. Our aim was to determine whether LPCAT attenuates lipotoxicity in the liver.

METHODS

Mice fed a high-fat diet with sucrose (HFDS) or high-fat diet without sucrose, and Huh-7 cells treated with palmitate were used.

RESULTS

Mice-fed HFDS showed advanced liver fibrosis as compared with mice-fed high-fat diet or normal chow. Lysophosphatidylcholine acyltransferase 3 (LPCAT3) mRNA expression in the liver was significantly decreased in the HFDS liver, and LPC content in the HFDS liver was significantly increased as compared with the other groups. When Huh-7 cells with short hairpin RNA-mediated knockdown of LPCAT3 (shLPCAT3 cells) were treated with palmitate, the intracellular LPC concentration and cell death were significantly higher than those in wild-type Huh-7 cells. Palmitate-induced cell death in shLPCAT3 was attenuated by a combination of receptor-interacting protein kinase 1 inhibitor with pan-caspase inhibitor. In contrast, intracellular LPC and palmitate-induced cell death were significantly lower in LPCAT3-overexpressing Huh-7 cells than in wild-type cells.

CONCLUSION

Depletion of LPCAT3 in a mouse model of NASH leads to caspase-independent cell death, and LPCAT3 is a potential therapeutic target in NASH.

摘要

背景和目的

脂毒性导致肝脏炎症,进而引发非酒精性脂肪性肝炎(NASH)。溶血磷脂酰胆碱(LPC)是脂毒性的一个致病因子。最近,溶血磷脂酰胆碱酰基转移酶(LPCAT)被鉴定为一种能催化 LPC 酯化的酶,这可能会降低 LPC 水平。然而,LPCAT 在肝脏脂毒性中的作用尚未完全阐明。我们的目的是确定 LPCAT 是否能减轻肝脏的脂毒性。

方法

使用高脂肪饮食加蔗糖(HFDS)喂养的小鼠和用棕榈酸处理的 Huh-7 细胞进行实验。

结果

与高脂肪饮食或正常饲料喂养的小鼠相比,HFDS 喂养的小鼠肝脏纤维化程度更严重。HFDS 肝组织中 LPCAT3 mRNA 表达明显降低,LPC 含量明显高于其他组。用短发夹 RNA 介导的 LPCAT3 敲低(shLPCAT3 细胞)处理 Huh-7 细胞后,用棕榈酸处理时,细胞内 LPC 浓度和细胞死亡明显高于野生型 Huh-7 细胞。用受体相互作用蛋白激酶 1 抑制剂联合全半胱氨酸蛋白酶抑制剂可减轻 shLPCAT3 诱导的细胞死亡。相反,与野生型细胞相比,LPCAT3 过表达 Huh-7 细胞中的细胞内 LPC 和棕榈酸诱导的细胞死亡明显降低。

结论

NASH 小鼠模型中 LPCAT3 的耗竭导致了 caspase 非依赖性细胞死亡,LPCAT3 是 NASH 的一个潜在治疗靶点。

相似文献

1
Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎中溶血磷脂酰胆碱酰基转移酶 3 减少导致的肝实质细胞凋亡:非依赖性机制。
J Gastroenterol Hepatol. 2019 Jul;34(7):1256-1262. doi: 10.1111/jgh.14461. Epub 2018 Sep 23.
2
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.脂质诱导的信号传导导致肝细胞释放炎性细胞外囊泡。
Gastroenterology. 2016 Apr;150(4):956-67. doi: 10.1053/j.gastro.2015.12.037. Epub 2016 Jan 5.
3
Integrin β-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH.整合素β富集的细胞外囊泡介导单核细胞黏附,并促进小鼠非酒精性脂肪性肝炎的肝脏炎症。
J Hepatol. 2019 Dec;71(6):1193-1205. doi: 10.1016/j.jhep.2019.07.019. Epub 2019 Aug 6.
4
Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis.溶血磷脂酰胆碱诱导肝细胞脂肪凋亡的机制。
Am J Physiol Gastrointest Liver Physiol. 2012 Jan 1;302(1):G77-84. doi: 10.1152/ajpgi.00301.2011. Epub 2011 Oct 13.
5
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.泛半胱天冬酶抑制剂恩瑞卡森(IDN-6556)可减轻非酒精性脂肪性肝炎小鼠模型中的肝损伤和纤维化。
Liver Int. 2015 Mar;35(3):953-66. doi: 10.1111/liv.12570. Epub 2014 Jun 6.
6
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.胰岛素抵抗促进非酒精性脂肪性肝病中赖氨酰氧化酶样蛋白2的诱导表达及纤维化积累。
Clin Sci (Lond). 2017 Jun 7;131(12):1301-1315. doi: 10.1042/CS20170175. Print 2017 Jun 1.
7
Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.肉豆蔻酸通过持续从头合成神经酰胺,增强棕榈酸诱导的与脂肪营养不良相关的脂毒性和脂肪性肝炎。
Oncotarget. 2015 Dec 8;6(39):41479-96. doi: 10.18632/oncotarget.6286.
8
Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression.溶血磷脂酰胆碱酰基转移酶 3 敲低介导的肝脏溶血磷脂酰胆碱积累通过增强微粒体甘油三酯转移蛋白表达促进极低密度脂蛋白的产生。
J Biol Chem. 2012 Jun 8;287(24):20122-31. doi: 10.1074/jbc.M111.334664. Epub 2012 Apr 17.
9
Identification and characterization of a major liver lysophosphatidylcholine acyltransferase.一种主要肝脏溶血磷脂酰胆碱酰基转移酶的鉴定与表征
J Biol Chem. 2008 Mar 28;283(13):8258-65. doi: 10.1074/jbc.M710422200. Epub 2008 Jan 14.
10
Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.细胞胆固醇蓄积在非酒精性脂肪性肝炎的发展过程中调节高脂肪高蔗糖(HFHS)饮食诱导的内质网应激和肝脏炎性小体激活。
Biochim Biophys Acta. 2016 Jul;1861(7):594-605. doi: 10.1016/j.bbalip.2016.04.005. Epub 2016 Apr 14.

引用本文的文献

1
Innovative approaches to metabolic dysfunction-associated steatohepatitis diagnosis and stratification.代谢功能障碍相关脂肪性肝炎诊断与分层的创新方法
Noncoding RNA Res. 2024 Oct 11;10:206-222. doi: 10.1016/j.ncrna.2024.10.002. eCollection 2025 Feb.
2
Probiotic therapy modulates the brain-gut-liver microbiota axis in a mouse model of traumatic brain injury.益生菌疗法可调节创伤性脑损伤小鼠模型的脑-肠-肝微生物群轴。
Biochim Biophys Acta Mol Basis Dis. 2024 Dec;1870(8):167483. doi: 10.1016/j.bbadis.2024.167483. Epub 2024 Aug 28.
3
Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review).
LXR-LPCAT3 信号通路中磷脂代谢的研究进展、挑战和展望及其与 NAFLD 的关系(综述)。
Int J Mol Med. 2024 Apr;53(4). doi: 10.3892/ijmm.2024.5356. Epub 2024 Feb 16.
4
Metabolomics and Lipidomics Study Unveils the Impact of Tauroursodeoxycholic Acid on Hyperlipidemic Mice.代谢组学和脂质组学研究揭示牛磺熊去氧胆酸对高脂血症小鼠的影响。
Molecules. 2023 Aug 30;28(17):6352. doi: 10.3390/molecules28176352.
5
Phosphatidylethanolamines Are Associated with Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Adults and Induce Liver Cell Metabolic Perturbations and Hepatic Stellate Cell Activation.磷脂酰乙醇胺与肥胖成年人的非酒精性脂肪性肝病(NAFLD)有关,并诱导肝细胞代谢紊乱和肝星状细胞激活。
Int J Mol Sci. 2023 Jan 5;24(2):1034. doi: 10.3390/ijms24021034.
6
Lpcat3 deficiency promotes palmitic acid-induced 3T3-L1 mature adipocyte inflammation through enhanced ROS generation.Lpcat3 缺乏通过增强 ROS 生成促进棕榈酸诱导的 3T3-L1 成熟脂肪细胞炎症。
Acta Biochim Biophys Sin (Shanghai). 2022 Nov 25;55(1):117-130. doi: 10.3724/abbs.2022161.
7
Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.尿细胞外囊泡的脂质组学鉴定用于非酒精性脂肪性肝炎的诊断。
J Nanobiotechnology. 2022 Jul 27;20(1):349. doi: 10.1186/s12951-022-01540-4.
8
Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer.LPCAT3在代谢相关疾病和癌症中的作用及机制的研究进展
J Cancer. 2022 May 1;13(8):2430-2439. doi: 10.7150/jca.71619. eCollection 2022.
9
The interaction between brain and liver regulates lipid metabolism in the TBI pathology.脑与肝之间的相互作用在创伤性脑损伤病理过程中调节脂质代谢。
Biochim Biophys Acta Mol Basis Dis. 2021 Apr 1;1867(4):166078. doi: 10.1016/j.bbadis.2021.166078. Epub 2021 Jan 12.
10
A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity.一种用于测量重组人溶血磷脂酰胆碱酰基转移酶3活性的新型检测方法。
FEBS Open Bio. 2019 Oct;9(10):1734-1743. doi: 10.1002/2211-5463.12712. Epub 2019 Aug 30.